In 2013, a study comparing human colon cancer specimens with healthy mucosa tissue presented selective up-regulation of CBS in cancer tissue, whereas low CBS expression levels were observed in non-cancerous peri-tumor tissue. This evidence concerns the gene CBS and malignant colon neoplasm.